INTRODUCTION THE EMERGENCE OF CYSTIC FIBROSIS (CF) as an eariy model
for human gene therapies has greatly accelerated the experimental development of m vivo gene delivery systems. Characterization of the distribution of CF gene expression in the non-CF lung suggests that bronchiolar epithelial cells are an important target for gene therapy of this disorder (Engelhardt et at., 1992 (Engelhardt et at., , 1994a ). The lung offers unique clinically practical and noninvasive approaches to gene therapy through inhalation of gene delivery vehicles.
Correction ofthe chloride (Cl) transport defect in cultured CF cells by virus-mediated transduction of a normal CF transmembrane conductance regulator (CFTR) gene was the first step toward the development of gene therapies. However, viruses used in these initial studies, murine retroviruses (Drumm etat., 1990 ) and human vaccinia viruses (Rich et at., 1990) , were not suitable for safe and efficient in vivo delivery to the lung. Crystal and co-workers utilized a vector system based on human adenoviruses to demonstrate the feasibility of efficient in vivo gene transfer to airway epithelial cells (Rosenfeld et at., 1991 (Rosenfeld et at., , 1992 .
Over 45 serotypes of human adenoviruses exist causing a variety of naturally acquired infections, including conjunctivitis, pharyngitis, and bronchitis (Horwitz, 1990 ). This nonenveloped family of viruses is comprised of linear doublestranded DNA genomes of approximately 36 kb in length. Expression of the immediate early genes Ela and Elb activate transcription ofthe delayed early genes that include E2, E3, and E4. Coincident with the onset of viral replication is the activation of the major late promoter and expression of the late gene products, which are primarily composed of structural proteins (for review, see Horwitz, 1990) . Human adenoviruses are rendered replication defective for applications in gene therapy by deletion of the immediate early genes and introduction of a minigene cassette that expresses the desired therapeutic function (Kozarsky and Wilson, 1993) . Propagation of these viruses in vitro have been made possible through the use of a cell line that provides Ela and Elb in trans (Graham et at., 1977) .
Feasibility of lung-directed gene therapy with recombinant adenoviruses was initially demonstrated in the cotton rat (Rosenfeld et at., 1991) . Previous studies evaluating wild-type AdS infections in lungs of cotton rats have suggested the utility of this model for studying the biology of naturally acquired human adenoviral infections (Ginsberg et at., 1991; Prince et at., 1993) . Human AdS is permissive for growth in cotton rat lung and, when instilled directly in the airway, simulates the naturally acquired pneumonia seen in human lung (Prince et at., 1993) . High-level recombinant gene expression in the majority of epithelial cells in the conducting airway was achieved when purified stocks of first-generation recombinant adenoviruses were directiy instilled into the airways of cotton rats (Mastrangeli et at., 1993; Yei et at., 1994) . This expression, however, was transient and associated with the development of inflammation at the site of transgene expression (Yei et al., 1994) . Identical results have been obtained in non-human primates (Engelhardt et at., 1993b; Simon et at., 1993) . Experience with the use of recombinant adenoviruses for gene therapy directed to other organs such as liver has yielded similar results (Yang et at., 1994a; Engelhardt et at., 1994b). Detailed characterization of adenovirus-mediated gene transfer to mouse liver and has implicated cellular immune responses as the primary mechanisms responsible for transgene instability and inflammation (Yang et at., 1994a) . The hypothesis that has emerged from this study is that first-generation recombinant adenoviruses express viral proteins that serve as antigens for cytotoxic T lymphocytes that lead to the destruction of genetically modified cells and repopulation of the liver with nontransgene-containing cells. An improved recombinant adenovirus that has been further disabled by inactivation of E2a, in addition to deletion of El, has proven useful in partially overcoming these problems in mouse liver (Engelhardt et at., 1994b) .
We have attempted in this study to characterize further the biology of first-generation recombinant adenoviruses in the application of lung-directed gene therapy in the cotton rat. The components of the recombinant virus will be reflected in its name as indicated in this figure. Included is an example of the virus used in this smdy which is based on human AdS and which expresses the lacZ gene from a CMV-enhanced P-actin promoter. The adenoviral genome in this construct contains a small deletion of E3b sequences from sub360 as well as a temperature-sensitive mutation in E2a derived from HStsl25. 
METHODS
Nomenclature of recombinant adenoviruses for gene therapy
The current generation of recombinant adenoviruses under development in our group at the University of Pennsylvania is based on human AdS, which has been deleted of El sequences spanning 1.0 to 9.4 map units (mu). To assist in the classification and presentation of this present E2a mutant and future second-generation recombinant adenoviruses constructed at the University of Pennsylvania, we have used the following nomenclature (Fig. 1) . Included in this nomenclature are the following viral components.
Species: The species from which the adenovirus was isolated is designated by a simple abbreviation. The most common form used in gene therapy is from humans (designated H); however, adenoviruses from a variety of other species are under development for human gene therapy.
Serotype: The serotype of the virus is indicated. The forms currentiy in use are designated 2 or 5.
E2: The locus of genes spanning the E2 open reading frames is indicated. Each genotype receives a numerical designation corresponding to the order in which they are constructed. We have currently assigned 0 for wild type and 1 for virus that has the HSts 12S mutation in E2a (Ensinger and Ginsberg, 1972) .
E3: The locus of genes spanning the E3 open reading frames have been assigned a numerical designation for each genotype. Current assignments are 0 for wild type, 1 for the small deletion in E3b found in sub360 (Logan and Shenk, 19S4) , and 2 for the 3.0-kb deletion found in rf/7001 (Engelhardt et at., 1993a).
E4: The locus of genes spanning the E4 open reading frames will also be assigned a numerical designation for each genotype. At present no assignments have been made other than 0 for wild type.
Other: If a virus contains modifications in regions outside of the early genes such as the late genes or ITRs, they will be given a numerical designation at this location. This position is usually omitted from the name unless it has a designation other than 0. Currently no assignments have been made.
Promoter: The transcriptional elements used to drive expression of the transgene are designated as an abreviation. Examples include CB for the cytomegalovirus (CMV)-enhanced P-actin promoter and CMV for the CMV promoter smd enhancer. These letters will always be capitalized.
Transgene: The open reading frame included in the recombinant transcript that translates the desired protein is designated with appropriate symbols or abbreviations. These letters will always be lowercase and in italics.
If more than 10 genotypes exist (0 for wild type and 1-9 for the first nine alterations) within one locus of genes, the designations will be according to sequential lowercase letters. A viral genome that is identical to wild type except for the deletion of El will be void of designations for E2, E3, E4, and others.
Generation of second-generation recombinant adenovirus
Two El-deleted recombinant lacZ adenoviral vectors, designated HS.OlOCB/acZ and HS.llOCB/acZ, were generated as previously described (Engelhardt et at., 1994b). H5.010 CBlacZ differs from H5.11 OCB/acZ by a single base pair substitution in the E2a gene that generates a temperature-sensitive viral DNA-binding protein (DBP) capable of growth at 32°C but not 39°C (Engelhardt et at., 1994b). The mutation contained within the recombinant adenoviral construct was generated from the wild-type AdS mutant strain HStsl2S (Ensinger and Ginsberg, 1972) . Expression ofthe lacZ transgene cassette, which is driven by the CMV enhancer and p-actin promoter, has been inserted within the El deleted region. In addition.
these vectors contain a small deletion within E3b that is found in sub360 (Logan and Shenk, 1984) . Purified viral stocks (averaging 1-3 X 10'^ particles/ml) were generated from crude lysates by propagation on 293 cells followed by two rounds of CsCl banding. CsCl was removed from the purified viral stocks by gel filtration through Sephadex G-SO in PBS before use in animal studies. It should be noted that both viral lysate and plaque growth of the HS.llOCB/acZ construct takes approximately twice as long at 32°C as compared to HS.OlOCB/acZ at 37°C. Typically, yields of viral lysate preparations from HS.l 1 OCB/acZ at 32°C are S0% thatof HS.OlOCB/acZat 37°C.
In vivo infection in cotton rat lungs
Male and female cotton rats (species) ranging from 7S to 12S grams were instilled with 1 x 10'° pfu of recombinant virus in a total volume of 100 p-1 PBS by midline incision. Animals were anesthetized with isoflourane. Following instillation of virus, the lungs were harvested at 3, 7, 14, and 21 days followed by inflation fixation with 0.5% glutaraldehyde in PBS for X-Gal staining in situ (Engelhardt etat., 1993b) or inflation with 37°C OCT (1:1 dilution of OCT in PBS) for histochemical, immunocytochemical, and in situ hybridization analysis of frozen sections. In a second set of experiments, animals were injected with 20 mg/kg cyclosporine the day before infusion of virus and each subsequent day until necropsy. At least 3 animals were analyzed per time point.
Histochemical and immunocytochemical analysis of ^-Gal, viral proteins, and inflammatory cell markers p-Gal transgene expression was analyzed by either paraffin sections of in situ X-Gal-stained tissue or by histochemical staining of frozen sections as described previously (Engelhardt etat., 1993a) . Detection of viral protein DBP, fiber, and hexon was analyzed in frozen (6-p.m) sections as described previously (Yang et al., 1994a ; Engelhardt et at., 1993a). Immunocytochemical staining for the CDS surface lymphocyte antigen was analyzed by immunofluorescent localization in frozen (6-p-m) sections postfixed in 100% ethanol for 20 min. Briefly, sections were incubated in 20% goat serum/PBS for 30 min followed by incubation in 1.5% goat serum/PBS containing S p,g/ml of mouse anti-rat-CDS-FITC for 90 min.
In situ hybridization detection of hexon mRNA
The expression of hexon mRNA was analyzed by in situ hybridization using a previously described protocol (Engelhardt etat., 1992) . PCR-amplified hexon sequences (50.9 mu to 53.1 mu) were generated with primers that contained T7 and SP6 RNA polymerase sites for riboprobe transcription. Controls included sense riboprobes and RNase pretreatment of the sections with 200 p-g/ml RNase A for 2 hr followed by paraformaldehyde fixation to inactivate RNase prior to hybridization.
Generation of cotton rat tracheal xenografts
Cotton rat tracheal xenografts were generated by modifications of a previously described protocol (Engelhardt etal., 1993a) in which tracheas from ISO-gram male cotton rats were ligated to flexible plastic tubing and transplanted subcutaneously in the flanks of athymic mice. Two weeks post-transplantation, tracheas were infused with 5 x 10''pfuof H5.010CB/acZvirusfora24-hr period. Tracheas were harvested and stained histochemically for the presence of p-Gal activity at 3 and 21 days post-infection.
RESULTS
Immune responses to viral antigens contribute to transgene instability and inflammation Adenovirus-mediated gene transfer to lung was initially characterized in adult cotton rats using a first-generation adenovirus that is deleted of Ela and Elb sequences, partially deleted of E3b, and contains the lacZ gene (i.e., HS.OlOCB/acZ). Animals instilled with virus directiy into the trachea (10'° pfu) were euthanized on subsequent days and evaluated for tacZ expression by X-Gal histochemistry (Fig. 2) . Analysis of tissues 7 days after virus instillation revealed tacZ expression throughout epithelial cells of the conducting airways as well as focal areas of significant expression in alveolar cells ( Fig. 2A) . Expression of tacZ dramatically diminished to undetectable levels by day 14 (Fig. 2D,E) . The role of the immune system in the performance of first-generation adenoviruses was studied in animals treated with cyclosporine prior to and following instillation of virus. In these animals, the stability of tacZ expression was increased in cells of both conducting and respiratory airway with only partial diminution for the duration of this experiment, which was 21 days (panels C, day 7; H and I, day 14; and N and O, day 21). This suggests that cellular immunity may play a role in the apparent loss of gene expression that is observed in cotton rat lung.
Cotton rats were evaluated for pathological effects of the recombinant adenovirus using the previously described histopathologic grading system of Ginsberg and co-workers (Prince et at., 1993). Lung tissues were characterized based on four criteria: (i) bronchiolar epithelial damage (as evident by nuclear inclusion bodies, nuclear condensation, loss of cilia, lymphocytic infiltration ofthe basement membrane), (ii) alveolar damage (as evident by an increase in the type II to type I cell ratios, interstitial thickening, and intraalveolar cellular infiltrate), (iii) peribronchial inflammatory inflltrate, and (iv) perivascular inflammatory infiltrate. Lungs were scored blindly on a 0-4 grading scale, with 4 being the most severe. Examples of various levels of histopathology are shown in Fig. 3A-D and the results are summarized in Fig. 3E . Significant pathology developed and peaked at day 14. Although all four types of pathology described above were observed, the most significant lesions were in the alveolar and peribronchiolar regions. Animals treated with cyclosporine demonstrated significantly less pathological changes in the lung as compared to untreated animals.
Specific components of the immune response that lead to the observed pathology in the lung in animals exposed to HS.OlOCB/acZ virus were further evaluated. remained elevated out to day 14 ( Fig. 4A ) with a retum to normal by day 21 (data not shown). CDS cells were distributed diffusely through the conducting and respiratory airway. Treatment of the animals with cyclosporine substantially lowered CDS cells in all regions of the lung at each time point (Fig. 4C) .
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First-generation recombinant adenoviruses express both early and late viral genes Lung tissues of animals infected with HS.OlOCB/acZ were analyzed for expression of early and late viral genes using techniques of immunocytochemistry and in situ hybridization. Protein products ofthe E2a, L3, and L5 viral genes that encode the DNA-binding protein (Fig. 5), hexon protein (Fig. 6) , and fiber protein (data not shown), respectively, were evaluated in frozen sections of lung by double immunofluorescence which colocalized p-Gal with the individual viral proteins. Significant levels of DBP (Fig. 5A ) and lower levels of hexon (Fig. 6) were detected in a minority of /acZ-expressing cells (<0.1%) in the conducting and respiratory airways. Lungs were also analyzed for expression of hexon RNA by in situ hybridization. Incubation of frozen sections with the antisense probe resulted in hybridization to a large number of cells in both the conducting and respiratory airways (Fig. 7A,B, Fig. 8, and Fig. 9A-C) . This signal was not detected when the sections were hybridized with a sense probe (Fig. 7B) or when the sections were treated with RNase prior to hybridization with the antisense probe (Fig.  8C) . Hexon RNA was detected by in situ hybridization in significantly more cells than the number that stained with the hexon antibody in immunocytochemical studies. This discordance could represent differences in the sensitivity of the techniques or a real difference in RNA versus protein expression due to post-transcriptional regulatory pathways. The lack of detectable hybridization to the sense probe or the antisense probe on RNase-pretreated sections confirms the specificity of the technique for hexon mRNA sequences.
Second-generation recombinant adenovirus results in prolonged transgene expression and a diminished CDS T cell response The studies described above in the cotton rat support our previous work in the mouse that implicates cellular immunity to viral antigens as a problem with first-generation adenoviral technology (Yang et al., 1994a,b) . The implication of this work is that further crippling the recombinant adenovirus to diminish or ablate viral protein expression should improve the stability of recombinant gene expression and blunt inflammation. We described in a previous study the design of a second-generation recombinant adenovirus that is defective in both El and E2a (Engelhardt et at., 1994b) . This virus, called HS.l lOCB/acZ, contains a previously described mutation in E2a that renders the resulting DNA-binding protein (DBP) sensitive to temperature in addition to the deletion of El and E3b, which has been incorporated into previous recombinant adenoviruses. HS.llOCB/acZ is easily grown in 293 cells at the permissive temperature of 32°C with approximately 50% viral yields as compared to that of HS.OlOCB/acZat 37°C. Additionally, virus replication and late gene expression is completely abolished when HS.llOCB/acZ is grown at the nonpermissive temperature of 39°C.
The distribution of lacZ expression obtained with HS. 11 OCB/acZ in cotton rat lung was indistinguishable from the results with HS.01 OCB/acZ when analyzed 7 days after instillation of virus (compare Fig. 2A to 2B) ; lacZ was detected in the majority of conducting airways and focally in patches within alveoli. With the second-generation virus, expression of lacZ in cells of the conducting airway (Fig. 2F and L) demonstrated increased stability for the duration of the experiment (i.e., 21 days), whereas alveolar cell expression diminished to undetectable levels within 14 days of instillation (Pig. 2G and M). This differs from the results obtained with the first-generation virus in which transgene expression was transient in all epithelial cells of the lung (see 14-day time point. Fig. 2D and E). There were no significant differences in the amount of inflammation observed between the first-and second-generation viruses (Fig. 3E) ; however, the infiltration of CDS "^ T cells into conducting airway epithelia was significantly diminished when using the second-generation virus (Fig. 4B) . No difference in the extent of CDS"^ T cell staining was seen in peribronchial, perivascular, or alveolar regions of the lung when comparing these two viruses.
Techniques of immunocytochemistry and in situ hybridization were used to characterize viral gene expression in animals that received H5.11 OCB/acZ. DBP protein was detected in the same number of cells found in HS.OlOCB/acZ-infected animals; however, the quantity of protein as judged by the intensity of fluorescence was markedly diminished with HS. 11 OCB/acZ (compare Fig. SA to SB) . Hexon protein was not detected in animals that received the second-generation virus (data not shown) in contrast with the limited but detectable hexon protein that was detected with the first generation virus (Fig. 6) . Hexon RNA was detected in alveolar but not conducting airway epithelial cells of animals that received the second-generation virus (Fig. 7C, Fig. 9D-F) , in contrast to the promiscuous expression of hexon RNA in all cell types observed with the first-generation virus (Fig. 7A, 8B , and Fig. 9A-C) .
Expression of adenoviral-mediated lacZ transgene expression is stable in cotton rat tracheas transplanted in athymic mice A xenograft model in which cotton rat trachea are grown in nu/nu mice was used to evaluate further the role of cellular immunity in the biology of first-generation recombinant adenoviruses. HS.OlOCB/acZ virus was instilled into the lumen ofthe tracheal xenografts 2 weeks after implantation (the time necessary for vascularization and recovery of epithelium following transplantation). Evaluation of lacZ transgene expression at 3 and 21 days postinfection showed no diminution in the level of P-Gal activity (Fig. 10) . Evaluation of paraffin sections failed to reveal any pathology after instillation of virus.
DISCUSSION
Preclinical models have been extremely important in the development of gene therapies for CF. Our initial work utilized a model in which human bronchial xenografts were grown in nu/nu mice (Engelhardt et at., 1993a) . Instillafion offirst-generation CFTR and lacZ adenoviruses into the xenograft resulted in efficient genetic reconstitution that was stable and without associated pathology. A subpopulation of adenovirus-transduced epithelial cells expressed substantial quantities of the eariy gene product of E2a, the DNA binding protein, indicating the possibility of franj-activation of viral promoters by El-like cellular factors in at least some airway epithelial cells. Our experience with first-generation recombinant adenoviruses in non-human primates was very different. Direct instillation of virus into the airway resulted in efficient and dose-dependent epithelial transgene expression. In contrast to the result in xenografts, transgene expression in non-human primates was transient and associated with substantial inflammation. Important differences in the models that could contribute to the disparate results are that the models differed with respect to the species of the target epithelium (human versus baboon) as well as the presence or absence of T cell-mediated immunity.
Experiments were then performed in mouse models to reconcile the important differences noted between human xenografts and non-human primates. The experience with CBA and C57B/6 mice instilled with first-generation virus into the lung was identical to that observed with non-human primates in that transgene expression was initially very efficient but over a 2-week period diminished to undetectable levels concurrent with the development of substantial inflammation (Yang et al., 1994b) . Similar experiments delivering recombinant adenovirus to the lungs of athymic nu/nu mice resulted in stable transgene expression without inflainmation (Yang et at., 1994b) . These and other experiments in the mouse liver (Yang et al., 1994a) suggested the following hypothesis to explain the limitations in first-generation adenoviral technology (i.e., transient expression and inflammation). It was proposed that first-generation recombinant adenoviruses express viral proteins, despite deletion of El, which stimulate cellular immune responses that destroy the genetically modified cells leading to repopulation of the epithelium with nontransgene-containing cells. A second generation virus, in which El is deleted and another essential gene (i.e., E2a) is inactivated by a temperature sensitive mutation, is associated with diminished viral gene expression, more prolonged transgene expression, and less inflammation when administered to liver in immune-competent mice (Engelhardt et at., 1994b). These results are consistent with the original hypothesis and suggest approaches for improving adenoviral technology for gene therapy.
The cotton rat was used in the current study to evaluate further the hypothesis of cellular immunity to adenoviral proteins and to test the potential usefulness of second-generation viruses. Ginsberg and colleagues have demonstrated the utility of both the mouse and cotton rat in studying biology of wildtype adenovirus, however, it appears that the cotton rat is substantially more permissive for adenovirus replication than is the mouse and, therefore, more closely resembles human with respect to biology of type C human adenoviruses (Ginsberg etal., 1990 (Ginsberg etal., , 1991 . Experiments performed with first-generation adenoviruses in the cotton rat confirm the essential elements of the original hypothesis. The role of cellular immunity to virus-transduced cells as an explanation for transient transgene expression was demonstrated in the cotton rat model by several independent experiments. Expression of the adenovirus-transduced gene, which was transient in airway epithelial cells of immune-competent animals, was shown to be stabilized when administered to cyclosporine-treated animals or when virus was delivered to cotton rat tracheas grown as xenografts in nu/nu mice. Furthermore, transgene expression could be prolonged in immune-competent animals if the recombinant adenovirus was modified so as to minimize viral protein expression.
The precise immune mechanisms responsible for the destruction of target cells and generalized inflammation are not known. Class I restricted cytotoxic T lymphocytes (CTL) to viral antigens have been detected in mediastinal lymph nodes of mice who received intratracheal recombinant adenovirus, suggesting, but not proving, that these cells may contribute to the clearance of virally infected cells (Yang et at., 1994b) . It appears that cellular immunity may also play a role in the cotton rat model based on the observed effect of cyclosporine and the result with tracheal xenografts grown in the athymic mouse. Infiltration of CDS-expressing cells into airway epithelia of immune-competent cotton rats infected with first-generation virus and their diminished presence in animals infected with second-generation virus is consistent with viral specific CTLs also contributing to clearance of virus-infected cells in the cotton rat model. CTL may be only one component of the inflammatory response that ensues following administration of large quantities of virus into cotton rat airway. Overall histopathology in the lung is indistinguishable between the first-and second-generation viruses, despite the diminished infiltration of CDS cells into the epithelium. This could be explained by direct toxicity ofthe virus, lack of a diminished CDS cellular response in alveolar regions ofthe lung, or non-antigen-specific immune responses such as those mediated by natural killer (NK) cells. In addition, it is likely that the mutant DBP in the second-generation virus is partially functional at the intermediate temperature of 37°C, potentially leading to low levels of viral specific CTLs (Engelhardt era/., 1994b).
Activation of viral promoters from the recombinant adenoviral genome by cellular El-like transcription factors is proposed to be the inciting event that stimulates the cascade of destructive immune responses. El complementing factors have been found in a variety of cell lines and appear to be subject to complex regulation (Nevins, 1981 ; Imperiale era/., 1984; Spergel era/., 1992). The cotton rat lung illustrates cell-specific regulation of El/E2a rrani-complementing function and demonstrates the biological implications in terms of the utility of recombinant adenoviruses for gene therapy. Hexon gene expression from first-generation virus was present in both alveolar and conducting airway epithelial cells (in both areas transgene expression is transient), whereas the level of hexon expression was unchanged in alveolar cells and greatly diminished in conducting airway epithelial cells of animals infected with the second generation virus (expression is stable in conducting airway and transient in alveoli). These experiments indicate complete concordance between late viral gene expression and loss of transgene expression, suggesting that hexon expression may be a useful end point for evaluating the likelihood of destructive cellular immune responses. Furthermore, these findings underscore the cell-specific importance of E2a function in the regulation of late viral gene expression from El-deleted vectors and the necessity to tailor vector construction based on biology of the target cell.
The studies in cotton rat lung presented in this report add to the growing body of knowledge that implicates cellular immunity to viral antigens as a confounding problem with recombinant adenovirus for application to gene therapy. Similar findings have been demonstrated in adenovirus-mediated gene transfer directed to mouse lung and liver (Yang et at., 1994a,b; Engelhardt et at., 1994b) . A more precise understanding of the immunology associated with the use of adenoviral technology will provide rational approaches for improvements as exemplified by the experience with the second-generation virus that is defective in both El and E2a.
